Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. NVDA
3. SPY
4. USO
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. SATL
10. LYNX

Go back to Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1144.75 +29.05 (2.60%)
Previous Close $1115.70    52 Week High $88.16 
Open $1142.20    52 Week Low $67.88 
Day High $1153.95    P/E 264.99 
Day Low $1130.50    EPS $4.32 
Volume 1,024,478